For its fourth fiscal quarter (ending December 31), HCA Healthcare Inc (NYSE: HCA) has reported a -6% decline in E.P.S. from $6.02 a year ago to $5.63 in the current quarter. For the latest four quarters through December 31, E.P.S. were $22.00 versus $19.25 for the same period a year ago — an increase of 14%.
Recent Price Action
HCA Healthcare Inc (NYSE: HCA) stock closed at $313.07 on 1/24/25 after a decline of -3.8%. Moreover, trading volume in this decline was exceptionally high at 204% of normal. The stock has performed in line with the market over the last nine months and has risen 2.2% during the last week.
Current PriceTarget Research Rating
HCA Healthcare is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment